Main menu

Webinar: Enhancing cell and gene therapy success with multi-omic sequencing


In this webinar, hear how GENEWIZ from Azenta uses nanopore sequencing technology to enhance the precision and efficiency of cell and gene therapy programs. It also highlights how scientists are using Oxford Nanopore’s real-time, long-read capabilities to understand genetic variations and to optimize the plasmids and AAVs used for gene therapy through enhanced vector characterization and quality control.

Authors: Dr Andrea O'Hara, GENEWIZ from Azenta, and Heather Stark, Oxford Nanopore Technologies

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag